المؤلفون: Sinakos E; 4th Department of Internal Medicine, Hippokratio Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece., Kachru N; Gilead Sciences Inc., Foster City, CA 94404, USA., Tsoulas C; Gilead Sciences Inc., Foster City, CA 94404, USA., Jeyakumar S; Maple Health Group, LLC, New York, NY 10019, USA., Smith NJ; Maple Health Group, LLC, New York, NY 10019, USA., Yehoshua A; Gilead Sciences Inc., Foster City, CA 94404, USA., Cholongitas E; First Department of Internal Medicine, Medical School of National & Kapodistrian University of Athens, Athens, Greece.

المصدر: Journal of comparative effectiveness research [J Comp Eff Res] 2024 Apr; Vol. 13 (4), pp. e230090. Date of Electronic Publication: 2024 Feb 06.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Becaris Publishing Country of Publication: England NLM ID: 101577308 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2042-6313 (Electronic) Linking ISSN: 20426305 NLM ISO Abbreviation: J Comp Eff Res Subsets: MEDLINE

مواضيع طبية MeSH: Hepatitis B, Chronic*/drug therapy , Liver Neoplasms*/drug therapy, Guanine/*analogs & derivatives, Humans ; Cost-Benefit Analysis ; Greece ; Tenofovir/therapeutic use ; Adenine ; Liver Cirrhosis/drug therapy ; Antiviral Agents/therapeutic use ; Treatment Outcome

المؤلفون: Papatheodoridis GV; Academic Department of Gastroenterology, Laiko General Hospital, Athens University Medical School, Athens, Greece; 2nd Department of Internal Medicine, Athens University Medical School, Hippokratio Hospital of Athens, Athens, Greece. Electronic address: gepapath@med.uoa.gr., Dalekos GN; Department of Medicine and Research Laboratory of Internal Medicine, School of Medicine, University of Thessaly, Larissa, Greece., Yurdaydin C; Department of Gastroenterology, University of Ankara Medical School, Ankara, Turkey., Buti M; Hospital General Universitario Valle Hebron and Ciberehd, Barcelona, Spain., Goulis J; Department of Internal Medicine, Αristotle University of Thessaloniki Medical School, Thessaloniki, Greece., Arends P; Department of Gastroenterology & Hepatology, ErasmusMC, Rotterdam, The Netherlands., Sypsa V; Department of Hygiene, Epidemiology & Medical Statistics, Athens University Medical School, Athens, Greece., Manolakopoulos S; 2nd Department of Internal Medicine, Athens University Medical School, Hippokratio Hospital of Athens, Athens, Greece., Mangia G; Division of Gastroenterology, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Università degli Studi di Milano, Milano, Italy., Gatselis N; Department of Medicine and Research Laboratory of Internal Medicine, School of Medicine, University of Thessaly, Larissa, Greece., Keskın O; Department of Gastroenterology, University of Ankara Medical School, Ankara, Turkey., Savvidou S; Department of Internal Medicine, Αristotle University of Thessaloniki Medical School, Thessaloniki, Greece., Hansen BE; Department of Gastroenterology & Hepatology, ErasmusMC, Rotterdam, The Netherlands., Papaioannou C; 2nd Department of Internal Medicine, Athens University Medical School, Hippokratio Hospital of Athens, Athens, Greece., Galanis K; Department of Medicine and Research Laboratory of Internal Medicine, School of Medicine, University of Thessaly, Larissa, Greece., Idilman R; Department of Gastroenterology, University of Ankara Medical School, Ankara, Turkey., Colombo M; Division of Gastroenterology, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Università degli Studi di Milano, Milano, Italy., Esteban R; Hospital General Universitario Valle Hebron and Ciberehd, Barcelona, Spain., Janssen HL; Department of Gastroenterology & Hepatology, ErasmusMC, Rotterdam, The Netherlands; Liver Clinic, Toronto Western & General Hospital, University Health Network, Toronto, ON, Canada., Lampertico P; Division of Gastroenterology, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Università degli Studi di Milano, Milano, Italy.

المصدر: Journal of hepatology [J Hepatol] 2015 Feb; Vol. 62 (2), pp. 363-70. Date of Electronic Publication: 2014 Sep 06.

نوع المنشور: Journal Article; Multicenter Study

بيانات الدورية: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 8503886 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-0641 (Electronic) Linking ISSN: 01688278 NLM ISO Abbreviation: J Hepatol Subsets: MEDLINE

مواضيع طبية MeSH: White People*, Adenine/*analogs & derivatives , Carcinoma, Hepatocellular/*ethnology , Guanine/*analogs & derivatives , Liver Neoplasms/*ethnology , Organophosphonates/*therapeutic use, Adenine/therapeutic use ; Adult ; Antiviral Agents/therapeutic use ; Carcinoma, Hepatocellular/etiology ; Female ; Follow-Up Studies ; Greece/epidemiology ; Guanine/therapeutic use ; Hepatitis B, Chronic/drug therapy ; Hepatitis B, Chronic/ethnology ; Humans ; Incidence ; Liver Neoplasms/etiology ; Male ; Middle Aged ; Netherlands/epidemiology ; Retrospective Studies ; Reverse Transcriptase Inhibitors/therapeutic use ; Risk Factors ; Spain/epidemiology ; Tenofovir ; Time Factors ; Turkey/epidemiology

المؤلفون: Papatheodoridis GV; Gastroenterology Department, Athens University Medical School, Laikon General Hospital of Athens, Athens, Attica, Greece., Manolakopoulos S, Touloumi G, Nikolopoulou G, Raptopoulou-Gigi M, Gogos C, Vafiadis-Zouboulis I, Karamanolis D, Chouta A, Ilias A, Drakoulis C, Mimidis K, Ketikoglou I, Manesis E, Mela M, Hatzis G, Dalekos GN

مؤلفون مشاركون: HepNet.Greece Study Group

المصدر: Journal of viral hepatitis [J Viral Hepat] 2015 Feb; Vol. 22 (2), pp. 120-7. Date of Electronic Publication: 2014 Jul 15.

نوع المنشور: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Blackwell Scientific Publications Country of Publication: England NLM ID: 9435672 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2893 (Electronic) Linking ISSN: 13520504 NLM ISO Abbreviation: J Viral Hepat Subsets: MEDLINE

مواضيع طبية MeSH: Antiviral Agents/*therapeutic use , Carcinoma, Hepatocellular/*epidemiology , Guanine/*analogs & derivatives , Hepatitis B e Antigens/*blood , Hepatitis B, Chronic/*complications , Hepatitis B, Chronic/*drug therapy , Liver Neoplasms/*epidemiology, Adult ; Cohort Studies ; Female ; Greece/epidemiology ; Guanine/therapeutic use ; Humans ; Incidence ; Lamivudine/therapeutic use ; Male ; Middle Aged ; Prospective Studies ; Risk Assessment ; Treatment Outcome